These results suggest that the Hv1 proton channel is a unique target for controlling NOX-dependent ROS production in the pathogenesis of MS and microglial Hv1 deficiency ameliorates demyelination through inhibition of ROS-mediated autophagy and microglial phenotypic transformation [84, 180]. This evidence concerns the gene HVCN1 and myeloid sarcoma.